Evidence-Based Treatment of Delirium in Patients With Cancer
- 10 April 2012
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (11), 1206-1214
- https://doi.org/10.1200/jco.2011.39.8784
Abstract
Delirium is the most common neuropsychiatric complication seen in patients with cancer, and it is associated with significant morbidity and mortality. Increased health care costs, prolonged hospital stays, and long-term cognitive decline are other well-recognized adverse outcomes of delirium. Improved recognition of delirium and early treatment are important in diminishing such morbidity. There has been an increasing number of studies published in the literature over the last 10 years regarding delirium treatment as well as prevention. Antipsychotics, cholinesterase inhibitors, and alpha-2 agonists are the three groups of medications that have been studied in randomized controlled trials in different patient populations. In patients with cancer, the evidence is most clearly supportive of short-term, low-dose use of antipsychotics for controlling the symptoms of delirium, with close monitoring for possible adverse effects, especially in older patients with multiple medical comorbidities. Nonpharmacologic interventions also appear to have a beneficial role in the treatment of patients with cancer who have or are at risk for delirium. This article presents evidence-based recommendations based on the results of pharmacologic and nonpharmacologic studies of the treatment and prevention of delirium.This publication has 76 references indexed in Scilit:
- Cerebrospinal Fluid β‐Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip FractureJournal of the American Geriatrics Society, 2011
- Administration of Olanzapine to Prevent Postoperative Delirium in Elderly Joint-Replacement Patients: A Randomized, Controlled TrialPsychosomatics, 2010
- Risperidone versus olanzapine for the treatment of deliriumHuman Psychopharmacology: Clinical and Experimental, 2010
- Rivastigmine in the treatment of delirium in older people: a pilot studyInternational Psychogeriatrics, 2010
- Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trialCritical Care, 2010
- Interventions for preventing delirium in hospitalised patientsPublished by Wiley ,2007
- Association Between Psychomotor Activity Delirium Subtypes and Mortality Among Newly Admitted Postacute Facility PatientsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2007
- Delirium in patients undergoing hematopoietic stem cell transplantationCancer, 2002
- The memorial delirium assessment scaleJournal of Pain and Symptom Management, 1997
- A critique of instruments and methods to detect, diagnose, and rate deliriumJournal of Pain and Symptom Management, 1995